Two Sigma Investments’s Connect Biopharma Holdings CNTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$124K Buy
+47,465
New +$124K ﹤0.01% 4361
2024
Q2
Sell
-10,805
Closed -$18.8K 3073
2024
Q1
$18.8K Sell
10,805
-600
-5% -$729 ﹤0.01% 2933
2023
Q4
$13.5K Sell
11,405
-5,814
-34% -$6.9K ﹤0.01% 3067
2023
Q3
$14.1K Sell
17,219
-6,367
-27% -$5.8K ﹤0.01% 2887
2023
Q2
$26.7K Buy
+23,586
New +$26.4K ﹤0.01% 2887
2022
Q3
Sell
-28,016
Closed -$24K 2518
2022
Q2
$24K Buy
+28,016
New +$41.3K ﹤0.01% 2393
2022
Q1
Sell
-15,632
Closed -$81K 2953
2021
Q4
$81K Buy
+15,632
New +$174K ﹤0.01% 4094

Other funds holding CNTB

Two Sigma Investments's CNTB Position: Q1 2026 in Review

Two Sigma Investments opened a new position in Connect Biopharma Holdings (CNTB) in Q1 2026: 47,465 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #4361 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in CNTB as recently as Q1 2024.

Two Sigma Investments first reported a position in CNTB in Q4 2021 and has held it in 7 quarters since. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Two Sigma Investments held 47,465 shares of Connect Biopharma Holdings worth $124K as of Q1 2026.
  • Connect Biopharma Holdings was a new Two Sigma Investments position in Q1 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4361 holding.
  • Two Sigma Investments first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 7 quarters since.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.